Skip to content
Back to browse
INTESTINAL Publication-derived

Intestinal Bioprinted and Engineered Tissues for Regenerative Medicine

Source Cruz-Acuña et al., 2018 · Georgia Institute of Technology; University of Michigan · 10.1038/s41596-018-0036-3

Authors: Ricardo Cruz-Acuña, Miguel Quirós, Sha Huang, Dorothée Siuda, Jason R. Spence, Asma Nusrat, Andrés J. García Duration: 21 days 5 phases Cell source: Human iPSC, Human ESC

Abstract

This protocol describes the synthesis and use of fully defined PEG-4MAL synthetic hydrogels to generate, culture, and deliver human pluripotent stem cell-derived organoids. The modular hydrogels replace Matrigel, offering tunable biochemical and biophysical properties to support robust in vitro organoid development and in vivo transplantation with minimal immune response.

Cell source
Human iPSC, Human ESC
Application
Organoid generation and culture; in vivo delivery to intestinal wounds

Protocol overview

18 steps across 5 phases

Phase 1 · Preparation of hydrogel precursor solutions Day 0 (1-2 h before encapsulation)
  1. a Equilibrate hydrogel components to room temperature
  2. b Weigh hydrogel precursors
  3. c Dissolve peptides in HEPES buffer
  4. d Filter peptide and buffer solutions
  5. e Dissolve PEG-4MAL macromer
  6. f Generate functionalized PEG-4MAL macromer and incubate
Phase 2 · Preparation of biological suspensions Day 0 (concurrent with Phase 1)
  1. a Prepare spheroid or organoid suspension
Phase 3 · Hydrogel casting and organoid encapsulation Day 0 (2.5-3.5 h total)
  1. a Mix functionalized PEG-4MAL with biological suspension
  2. b Dispense cross-linker into culture wells
  3. c Pipette functionalized PEG-4MAL and cell mixture into cross-linker
  4. d Incubate hydrogels for cross-linking
  5. e Overlay hydrogels with culture medium
Phase 4 · Organoid expansion and passaging Days 1-21+ (passaging every 7-10 d)
  1. a Monitor organoid growth and passage when ready
Phase 5 · In vivo delivery to colonic mucosal wounds Day 0 (Day -1 for wounding; ~5 h for delivery on Day 1)
  1. a Induce colonic mucosal wounds (Day -1)
  2. b Prepare organoids for injection (Day 0, concurrent with wounding day +1 h)
  3. c Assemble custom injection device and load solutions
  4. d Mix organoids with functionalized PEG-4MAL and load syringe
  5. e Perform colonoscopic injection into wound

Full SOP

Full SOPs need an account and a plan

Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.

Create an account

Already registered? Log in

Attribution

This SOP was written by Organthis based on the published method in Cruz-Acuña et al., 2018. Once the originating laboratory has confirmed it, the SOP is marked Verified.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?
Use this protocol in your therapeutic or diagnostic pipeline.